HSPA5 and hepatocellular carcinoma: To determine whether elevated extracellular FFAs is sufficient to induce loss of Grp78/BiP protein, we treated a liver cell line derived from murine hepatoma, Hepa1–6 cells, with elevated palmitate coupled to BSA.